N-[1-((5-cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl]-2-[4-(1-(trifluoromethyl)cyclopropyl)phenyl]acetamide ( DrugBank: Acetamide, 1H-Pyrazol )

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
154徐波睡眠期持続性棘徐波を示すてんかん性脳症0

154. 徐波睡眠期持続性棘徐波を示すてんかん性脳症

臨床試験数 : 7 / 薬物数 : 4 - (DrugBank : 3) / 標的遺伝子数 : 13 - 標的パスウェイ数 : 7 
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries